In Situ Pt Staining Method for Simple, Stable, and Sensitive Pressure-Based Bioassays.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Analytical Chemistry

Background:

• Pressure-based bioassays (PASS) offer sensitive and portable biomarker quantitation.
• Platinum nanoparticles (PtNPs) improve PASS sensitivity but suffer from deactivation and nonspecific adsorption.
• Existing PtNP limitations hinder reliable clinical applications.

Purpose of the Study:

• To develop a robust, stable, and sensitive platinum staining method for PASS.
• To overcome the deactivation and background issues associated with traditional PtNPs.
• To enhance the applicability of PASS in clinical diagnostics.

Main Methods:

• Developed a Pt staining technique to create Ag and Pt bimetallic shells (Au@AgPtNPs) on antibody-decorated gold nanoparticles (AuNPs).
• Utilized Au@AgPtNPs as catalysts for hydrogen peroxide decomposition, generating measurable O2 gas pressure.
• Quantified target biomarkers via pressure changes, employing an enzyme-linked immunosorbent assay (ELISA) format.

Main Results:

• Achieved sensitive detection of C-reactive protein (CRP) at 0.015 ng/mL and avian influenza hemagglutinin (HA) at 0.065 ng/mL.
• Demonstrated enhanced stability and reduced background noise compared to previous PtNP-based methods.
• Validated the Pt staining method's robustness and sensitivity for biomarker quantitation.

Conclusions:

• The Pt staining method provides a stable, sensitive, and simple approach for PASS.
• This advancement addresses key limitations of PtNP-based detection in bioassays.
• The improved method holds significant potential for broadening PASS applications in clinical diagnosis and biomedicine.